About Chemo India Formulation Private Limited
Data last updated:
Chemo India Formulation Private Limited is a foreign private limited company based in Hyderabad, Telangana, India, a subsidiary of Chemo Holdings Sl. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 August 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85100TG2015FTC100239. Its GSTIN is 36AAGCC1775K1ZE (Telangana).
The company has an authorised share capital of ₹130 Cr and a paid-up capital of ₹122.36 Cr. It is led by directors including Ramachandra Kumar Kurumaddali (Managing Director) and Maria Sandra Martin Moran.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 2B & 2C Biotech Park Phase II Lalgadi Malakpet Hyderabad, Telangana, India – 500078.
As per the financials filed for FY 2025, the company reported a revenue of ₹106.58 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net loss of ₹2.13 Lakh (net margin 0%) and EBITDA of ₹26.14 Cr (EBITDA margin 24.5%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 26% over five years.
The company has about 225 employees on its provident fund (EPFO) records.
The company has 6 deals on record (4 rights issues, 2 convertible or debt financings), with disclosed funding of ₹31.47 Cr; the latest was in January 2019.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website chemopharmaceuticals.com.
Company details
Contact details
Chemo India Formulation Private Limited's registered office is in Hyderabad, Telangana. Its website is chemopharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 2B & 2C Biotech Park Phase II Lalgadi Malakpet Hyderabad, Telangana, India – 500078
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Chemo India Formulation Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Chemo India Formulation is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Chemo India Formulation Private Limited, buy the company report.
Financials of Chemo India Formulation Private Limited
FY 2025 filings availableChemo India Formulation Private Limited reported revenue of ₹106.58 Cr (up 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 21% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹26.14 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.13 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 24.5% | ||||
| Net Profit Margin | 0% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Chemo India Formulation Private Limited, buy the company report.
Board of directors of Chemo India Formulation Private Limited
Chemo India Formulation has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Maria Sandra Martin Moran Also directs: Ordain Health Care Global Private Limited | Director | 13 Aug 2015 | 11 Years 2 Months | Current |
| Bharat Vasudevan | Director | 06 Jun 2019 | 7 Years 4 Months | Current |
| Manuel Ignacio Barro | Director | 06 Jun 2019 | 7 Years 4 Months | Current |
| Ramachandra Kumar Kurumaddali | Managing Director | 13 Aug 2015 | 11 Years 2 Months | Current |
Auditor
Chemo India Formulation Private Limited is audited by MSKA & Associates for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MSKA & Associates | FY 2025 | 105047W |
Shareholding
The shareholding of Chemo India Formulation Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Chemo India Formulation Private Limited, buy the company report.
Deals & funding
Chemo India Formulation Private Limited has 6 deals on record (4 rights issues, 2 convertible or debt financings), with disclosed funding of ₹31.47 Cr; the latest was in January 2019.
Deals on record (4 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2019 | Rights issue | ₹6.96 Cr | Investors: Chemo Holding SL |
| Sep 2018 | Rights issue | ₹10.4 Cr | Investors: Chemo Holding SL |
| May 2017 | Rights issue | ₹83.78 Cr | Investors: Chemo Holding SL |
| Oct 2015 | Rights issue | ₹4.26 Cr | Investors: Chemo Holding SL |
To see the full deal history of Chemo India Formulation Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Chemo India Formulation Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Chemo India Formulation Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Chemo India Formulation Private Limited has a workforce of 225 employees on its EPFO records as of Sep 23, 2025, across 1 active EPFO establishment.
GST
Chemo India Formulation has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCC1775K1ZE | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Chemo India Formulation Private Limited, buy the company report.
Recent activity
Chemo India Formulation Private Limited has 8 board changes on record since 2015: 5 appointments and 3 cessations. The latest: Satheesh Rao Ponugoti was appointed as Company Secretary on 01 Oct 2023.
Frequently asked questions
Chemo India Formulation is an active foreign private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 August 2015 (11+ years old) and is registered under CIN U85100TG2015FTC100239.
Chemo India Formulation has 4 current directors:
- Ramachandra Kumar Kurumaddali - Managing Director
- Maria Sandra Martin Moran - Director
- Bharat Vasudevan - Director
- Manuel Ignacio Barro - Director
The latest financial statements of Chemo India Formulation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Chemo India Formulation is 36AAGCC1775K1ZE, registered in Telangana.
The CIN (Corporate Identification Number) of Chemo India Formulation is U85100TG2015FTC100239. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Chemo India Formulation was incorporated on 13 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
Chemo India Formulation has 6 deals on record (4 rights issues, 2 convertible or debt financings), with disclosed funding of ₹31.47 Cr; the latest was in January 2019.
Satheesh Rao Ponugoti was appointed as Company Secretary on 01 Oct 2023. Ramachandra Kumar Kurumaddali ceased to be Managing Director on 27 Sep 2021. Bharat Vasudevan ceased to be Additional Director on 30 Sep 2019. Chemo India Formulation has 8 board changes on record in total.
Chemo India Formulation can be reached through the website chemopharmaceuticals.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Chemo India Formulation is at Plot No. 2B & 2C Biotech Park Phase II Lalgadi Malakpet Hyderabad, Telangana, India – 500078.